Growth Metrics

LifeMD (LFMD) Cash & Current Investments (2016 - 2025)

LifeMD (LFMD) has disclosed Cash & Current Investments for 14 consecutive years, with $37.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Current Investments rose 13.5% year-over-year to $37.1 million, compared with a TTM value of $37.1 million through Dec 2025, up 13.5%, and an annual FY2025 reading of $37.1 million, up 13.5% over the prior year.
  • Cash & Current Investments was $37.1 million for Q4 2025 at LifeMD, up from $24.2 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $41.5 million in Q4 2021 and bottomed at $1.4 million in Q2 2021.
  • Average Cash & Current Investments over 5 years is $23.1 million, with a median of $24.9 million recorded in 2022.
  • The sharpest move saw Cash & Current Investments skyrocketed 4009.48% in 2021, then crashed 90.16% in 2022.
  • Year by year, Cash & Current Investments stood at $41.5 million in 2021, then tumbled by 90.16% to $4.1 million in 2022, then soared by 723.07% to $33.6 million in 2023, then decreased by 2.79% to $32.7 million in 2024, then increased by 13.5% to $37.1 million in 2025.
  • Business Quant data shows Cash & Current Investments for LFMD at $37.1 million in Q4 2025, $24.2 million in Q3 2025, and $36.5 million in Q2 2025.